942 related articles for article (PubMed ID: 33888679)
1. Extracellular matrix and its therapeutic potential for cancer treatment.
Huang J; Zhang L; Wan D; Zhou L; Zheng S; Lin S; Qiao Y
Signal Transduct Target Ther; 2021 Apr; 6(1):153. PubMed ID: 33888679
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix remodeling in the tumor immunity.
Du W; Xia X; Hu F; Yu J
Front Immunol; 2023; 14():1340634. PubMed ID: 38332915
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation in the tumor microenvironment.
Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
5. The cancer matrisome: From comprehensive characterization to biomarker discovery.
Socovich AM; Naba A
Semin Cell Dev Biol; 2019 May; 89():157-166. PubMed ID: 29964200
[TBL] [Abstract][Full Text] [Related]
6. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.
Jiang Y; Zhang H; Wang J; Liu Y; Luo T; Hua H
J Hematol Oncol; 2022 Mar; 15(1):34. PubMed ID: 35331296
[TBL] [Abstract][Full Text] [Related]
7. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies.
Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X
Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177
[TBL] [Abstract][Full Text] [Related]
8. Fighting the force: Potential of homeobox genes for tumor microenvironment regulation.
Northcott JM; Northey JJ; Barnes JM; Weaver VM
Biochim Biophys Acta; 2015 Apr; 1855(2):248-53. PubMed ID: 25818365
[TBL] [Abstract][Full Text] [Related]
9. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability.
Roy AM; Iyer R; Chakraborty S
Cell Rep Med; 2023 Sep; 4(9):101170. PubMed ID: 37652015
[TBL] [Abstract][Full Text] [Related]
10. The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
Jurj A; Ionescu C; Berindan-Neagoe I; Braicu C
J Exp Clin Cancer Res; 2022 Sep; 41(1):276. PubMed ID: 36114508
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
[TBL] [Abstract][Full Text] [Related]
12. Targeting the microenvironment in solid tumors.
Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
[TBL] [Abstract][Full Text] [Related]
13. Matrix stiffness epigenetically regulates the oncogenic activation of the Yes-associated protein in gastric cancer.
Jang M; An J; Oh SW; Lim JY; Kim J; Choi JK; Cheong JH; Kim P
Nat Biomed Eng; 2021 Jan; 5(1):114-123. PubMed ID: 33288878
[TBL] [Abstract][Full Text] [Related]
14. The Tumor Microenvironment: Focus on Extracellular Matrix.
Rigoglio NN; Rabelo ACS; Borghesi J; de Sá Schiavo Matias G; Fratini P; Prazeres PHDM; Pimentel CMMM; Birbrair A; Miglino MA
Adv Exp Med Biol; 2020; 1245():1-38. PubMed ID: 32266651
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation and targeting of ECM for cancer therapy.
Gupta R
Am J Physiol Cell Physiol; 2022 Apr; 322(4):C762-C768. PubMed ID: 35235427
[TBL] [Abstract][Full Text] [Related]
16. The Mammary Tumor Microenvironment.
Curran CS; Ponik SM
Adv Exp Med Biol; 2020; 1296():163-181. PubMed ID: 34185292
[TBL] [Abstract][Full Text] [Related]
17. Beyond matrix stiffness: targeting force-induced cancer drug resistance.
Kalli M; Poskus MD; Stylianopoulos T; Zervantonakis IK
Trends Cancer; 2023 Nov; 9(11):937-954. PubMed ID: 37558577
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of ECM remodeling processes in cancer.
Mohan V; Das A; Sagi I
Semin Cancer Biol; 2020 May; 62():192-200. PubMed ID: 31518697
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview.
Noguera R; Nieto OA; Tadeo I; Fariñas F; Alvaro T
Histol Histopathol; 2012 Jun; 27(6):693-705. PubMed ID: 22473691
[TBL] [Abstract][Full Text] [Related]
20. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.
Niland S; Eble JA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
